TL;DR
This study reveals that the probiotic Lacticaseibacillus rhamnosus GG (LGG) protects against Salmonella Typhimurium (STM) infection by activating a specific immune pathway. LGG stimulates dendritic cells (DCs) via the TLR2 receptor, leading to IL-23 production, which in turn activates innate lymphoid cells (ILC3s) to secrete IL-22. This IL-22 then strengthens the intestinal barrier, offering a promising therapeutic strategy against STM.
What Problem Does This Paper Address?
Salmonella Typhimurium (STM) is a significant foodborne pathogen responsible for acute gastroenteritis, causing severe disruption of the intestinal mucosal immune system. While probiotics are known to offer health benefits, the precise mechanisms by which they protect against specific pathogens like STM are not always fully understood. This paper aims to elucidate how the widely studied probiotic Lacticaseibacillus rhamnosus GG (LGG) confers protection against STM infection, focusing on its impact on the host's innate immune system, particularly type 3 innate lymphoid cells (ILC3s).
Methods
The researchers employed a multi-pronged approach:
- In vivo infection models: Mice were infected with STM, and their weight changes, survival rates, and intestinal pathology were assessed.
- Probiotic intervention: Mice were fed LGG before or during STM infection to evaluate its protective effects.
- Genetic manipulation: Experiments using TLR2 knockout (TLR2<sup>-/-</sup>) mice were crucial to pinpoint the role of the TLR2 receptor in LGG's mechanism.
- In vitro co-culture systems: Dendritic cells (DCs) and ILC3s were co-cultured to study their interactions and cytokine production in response to LGG or its components.
- Organoid culture: Intestinal organoids were used to model the intestinal environment and assess the impact of IL-22 on barrier function and development.
- Flow cytometry: This technique was extensively used to quantify immune cell populations (like ILC3s and DCs) and measure cytokine expression (IL-22, IL-23).
- ELISA and qPCR: These methods were used to measure protein levels and gene transcription of key cytokines, respectively.
- 16S rRNA sequencing: This was used to analyze changes in the gut microbiota composition following STM infection.
- Histopathology and Immunofluorescence: These techniques were employed to examine tissue damage and the expression of specific intestinal epithelial markers.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- LGG's Protective Role: LGG significantly alleviates the detrimental effects of STM infection, reducing mortality, weight loss, and intestinal damage.
- ILC3s as Key Mediators: STM infection leads to an increase in ILC3s and IL-22 secretion, suggesting their involvement in the host's response. LGG appears to enhance this protective response.
- TLR2 is Essential: The protective effects of LGG are dependent on the TLR2 receptor, highlighting its critical role in initiating the immune cascade.
- DCs Bridge LGG and ILC3s: Dendritic cells (DCs) act as intermediaries, with TLR2 on DCs being crucial for LGG's ability to activate ILC3s.
- IL-23 as a Signal: Heat-killed LGG (HK-LGG) stimulates DCs to produce IL-23, which then acts on ILC3s.
- IL-22's Barrier Function: IL-22 secreted by ILC3s is shown to enhance the intestinal mucosal immune barrier, directly inhibiting STM infection.
- Microbiota Shift: STM infection alters the gut microbiota, increasing the proportion of Lacticaseibacillus, which may play a role in the host's response.
Key Results
- STM infection caused significant weight loss and mortality (25% survival rate by day 8) in mice.
- Feeding LGG to infected mice significantly improved survival rates and reduced weight loss compared to the PBS-STM group.
- Infection with STM led to a significant increase in IL-22 secretion and IL-22 gene transcription in the mouse intestine.
- TLR2<sup>-/-</sup> mice showed an absence of LGG-mediated ILC3 activation and IL-22 secretion, confirming TLR2's essential role.
- HK-LGG stimulated DCs to secrete IL-23, and this IL-23, in turn, promoted IL-22 secretion by ILC3s in vitro.
- IL-22 secreted by ILC3s was shown to promote the growth and development of intestinal organoids, indicating its role in barrier function.
Limitations and Future Work
The authors acknowledge that the complexity of microbial species in the intestine leaves unanswered questions about whether LAM and LTA from other microbial sources can exert similar immunomodulatory effects. They also note that while their work provides a theoretical basis for intestinal health products, the interactions between microbiota and the immune system are still not fully understood. Future work will delve deeper into exploring the mechanisms of interaction between LGG and intestinal immune cells. The study also suggests that further research is needed to explore whether IL-22 could further enhance the function of the intestinal mucosal immune barrier.
Summary updated